The packaging and maturation of the HIV-1 pol proteins

被引:49
作者
Hill, M
Tachedjian, G
Mak, J
机构
[1] Macfarlane Burnet Inst Med Res & Publ Hlth, Virol Program, Melbourne, Vic 3001, Australia
[2] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia
[3] Monash Univ, Dept Med, Clayton, Vic 3168, Australia
[4] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia
关键词
Gag-Pol; HIV-1; protease; reverse transcriptase; integrase;
D O I
10.2174/1570162052772942
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Pol protein of human immunodeficiency virus type 1 (HIV-1) harbours the viral enzymes critical for viral replication; protease (PR), reverse transcriptase (RT), and integrase (IN). PR, RT and IN are not functional in their monomeric forms and must come together as either dimers (PR), heterodimers (RT) or tetramers (IN) to be catalytically active. Our knowledge of the tertiary structures of the functional enzymes is well advanced, and substantial progress has recently been made towards understanding the precise steps leading from Pol protein synthesis through viral assembly to the release of active viral enzymes. This review will summarise our current understanding of how the Pol proteins, which are initially expressed as a Gag-Pot fusion product, are packaged into the assembling virion and discuss the maturation process that results in the release of the viral enzymes in their active forms. Our discussion will focus on the relationship between structure and function for each of the viral enzymes. This review will also provide an overview of the current status of inhibitors against the HIV-1 Pol proteins. Effective inhibitors of PR and RT are well established and we will discuss the next generation inhibitors of these enzymes as well recent investigations that have highlighted the potential of IN and RNase H as antiretroviral targets.
引用
收藏
页码:73 / 85
页数:13
相关论文
共 204 条
[1]   A putative α-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly [J].
Accola, MA ;
Höglund, S ;
Göttlinger, HG .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2072-2078
[2]   Structural studies of the RNA pseudoknot required for readthrough of the gag-termination codon of murine leukemia virus [J].
Alam, SL ;
Wills, NM ;
Ingram, JA ;
Atkins, JF ;
Gesteland, RF .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 288 (05) :837-852
[3]   A p6(Pol)-protease fusion protein is present in mature particles of human immunodeficiency virus type 1 [J].
Almog, N ;
Roller, R ;
Arad, G ;
PassiEven, L ;
Wainberg, MA ;
Kotler, M .
JOURNAL OF VIROLOGY, 1996, 70 (10) :7228-7232
[4]   Expression of human immunodeficiency virus type 1 reverse transcriptase in trans during virion release and after infection [J].
AnsariLari, MA ;
Gibbs, RA .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3870-3875
[5]   POTENT INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION BY INDUCIBLE EXPRESSION OF HIV-1 PR MULTIMERS [J].
ARRIGO, SJ ;
HUFFMAN, K .
JOURNAL OF VIROLOGY, 1995, 69 (10) :5988-5994
[6]   Efficiency of a programmed-1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M [J].
Baril, M ;
Dulude, D ;
Gendron, K ;
Lemay, G ;
Brakier-Gingras, L .
RNA, 2003, 9 (10) :1246-1253
[7]  
Bidou L, 1997, RNA, V3, P1153
[8]  
Billich Andreas, 2003, Curr Opin Investig Drugs, V4, P206
[9]   The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy [J].
Biswas, P ;
Jiang, X ;
Pacchia, AL ;
Dougherty, JP ;
Peltz, SW .
JOURNAL OF VIROLOGY, 2004, 78 (04) :2082-2087
[10]   Association of murine leukemia virus Pol with virions, independent of Gag-Pol expression [J].
Buchschacher, GL ;
Yu, L ;
Murai, F ;
Friedmann, T ;
Miyanohara, A .
JOURNAL OF VIROLOGY, 1999, 73 (11) :9632-9637